Pharmacodynamic effects of seliciclib, an orally administered cell cycle modulator, in undifferentiated nasopharyngeal cancer

由 Hsieh, W.-S., Soo, R., Pen, B.-K., Loh, T., Dong, D., Son, D., Wong, L.-S., Green, S., Chiao, J., Cui, C.-Y., Lai, Y.-F., Lee, S.-C., Mow, B., Soong, R., Salto-Tellez, M., Goh, B.-C.
出版 2014